ArticlePharmaceuticals (Basel, Switzerland)2024

Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors.

Selin Genc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.